A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Primary Membranous Nephropathy Diagnostic Cascade, Serum
Test CodePMND1
Alias/See Also
Anti-PLA2R, PLA2R, Anti-THSD7A, Thrombospondin, THSD7
CPT Codes
83520
Includes
The phospholipase A2 receptor (PLA2R) enzyme-linked
immunosorbent assay (ELISA) is initially performed.
If the PLA2R ELISA result is less than 20, then the PLA2R
immunofluorescence testing will be performed at an
additional charge.
If the PLA2R immunofluorescence result is negative,
thrombospondin type-1 domain-containing 7A (THSD7A) antibody
testing will be performed at an additional charge.
immunosorbent assay (ELISA) is initially performed.
If the PLA2R ELISA result is less than 20, then the PLA2R
immunofluorescence testing will be performed at an
additional charge.
If the PLA2R immunofluorescence result is negative,
thrombospondin type-1 domain-containing 7A (THSD7A) antibody
testing will be performed at an additional charge.
Preferred Specimen
1 mL serum
Minimum Volume
1 mL serum
Instructions
Centrifuge and aliquot serum into plastic vial within 2 hours of collection.
Transport Container
Plastic vial
Transport Temperature
Refrigerated
Specimen Stability
Room temperature: 8 hours
Refrigerated: 14 days
Frozen: 14 days
Refrigerated: 14 days
Frozen: 14 days
Methodology
EURO: Enzyme-Linked Immunosorbent Assay (ELISA), PLA2I, THSD7: Indirect Immunofluorescence Assay (IFA)
Setup Schedule
Monday, Wednesday, Friday
Report Available
3-7 days
Clinical Significance
Distinguishing primary from secondary membranous nephropathy
using an algorithmic approach
Monitoring patients with membranous nephropathy at very low
antibody titers
Screening for anti-phospholipase A2 receptor antibodies
using an algorithmic approach
Monitoring patients with membranous nephropathy at very low
antibody titers
Screening for anti-phospholipase A2 receptor antibodies
Performing Laboratory
Mayo Clinic Laboratories
200 First St
Rochester, MN 55905